Prothionamide.html |
| | | ca | | | de | | | en | | | es | | | fr | | | it | | | nl | | | no | | | pl | | | pt | | | ru | | | ro | | | fi | | | sv | | | tr | | | vo | | |
| |  |
 |
|
|
Protionamide
|
|
| Systematic (IUPAC) name | |
| 2-propylpyridine-4-carbothioamide | |
| Identifiers | |
| CAS number | |
| ATC code | J04 |
| PubChem | |
| Chemical data | |
| Formula | C9H12N2S |
| Mol. mass | 180.271 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |